by Jason Heaviland | Jul 22, 2026
How Exposomics Can Improve Clinical Trials and Precision Medicine Why do promising drugs fail in Phase III clinical trials? Why do patients respond differently to the same therapy across countries? And if genetics only explains part of disease risk, what information...
by Jason Heaviland | Jul 16, 2026
How are exposure patterns linked to biological pathways? Environmental chemical exposures can significantly influence drug metabolism, therapeutic response, and disease biology—but they are often overlooked in biomedical research and clinical development.In this...
by ODWAdmin | Mar 27, 2024
ChatGJP “Metabolomics for drug development” Welcome to Panome Bio’s ChatGJP series with CSO Gary J. Patti, Ph.D. In this session, we ask Dr. Patti, “How is metabolomics being employed in drug development and pharmacology to enhance the efficiency of...
